NYAS - Vaccines and Alternate Strategies for Treatment and Prevention

This one day symposium will cover a range of challenges facing researchers working towards the development of an HIV / AIDS vaccine, and will counter each presented challenge with a possible solution. The challenges include: developing HIV vaccines to prevent or control infection, genetic diversity of the virus, and predictive models of infection. The symposium will also cover other (non-scientific) challenges and mechanisms that can be used to reduce HIV transmission now and in conjunction with a future vaccine.

Wednesday, May 19, 2010, 9 am - 5 pm

The New York Academy of Sciences
7 World Trade Center | 250 Greenwich St., 40th Floor
New York, NY

Sponsored by:
The Global HIV Vaccine Enterprise and The New York Academy of Sciences Vaccine Science Discussion Group.

Organizers: 
• Sarah Schlesinger, MD, (The Rockefeller University)
• Yegor Voronin, PhD, (Global HIV Vaccine Enterprise)
• Jennifer Henry, PhD, (The New York Academy of Sciences)

Speakers: 
• Dan Barouch (Beth Israel Deaconess Medical Center)
• Alan Bernstein (Global HIV Vaccine Enterprise)
• Jerome Kim (Walter Reed Army Institute of Research)
• Julie McElrath (Fred Hutchinson Cancer Research Center)
• Chris Miller (University of California)
• Louis Picker (Oregon Health & Sciences University)
• Sanjay Phogat (International AIDS Vaccine Initiative)
• Harriet L. Robinson (GeoVax Inc.)
• Michael Worobey (University of Arizona)
• Susan Zolla-Pazner (NYU Langone School of Medicine)

Registration Information

• $10 - All NYAS Members
• $65 - Non-Member (Corporate)
• $45 - Non-Member (Academic/Non-Profit)
• $25 - Non-Member (Student/Postdoc)

Register at www.nyas.org/AIDS

For additional info, e-mail nymeetings@nyas.org or call 212-298-3725

Speakers and topics include:   

Genetic Diversity in HIV

  • Dan Barouch, Associate Professor of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School
  • Michael Worobey, Associate Professor, Department of Ecology and Evolutionary Biology, University of Arizona   

Neutralizing Ab Reactions to HIV

  • Sanjay Phogat, Principal Scientist, International AIDS Vaccine Initiative
  • Susan Zolla-Pazner, NYU Langone School of Medicine 

Non-human Primate Models

  • Louis Picker, Oregon Health & Sciences University
  • Christopher Miller, Professor of Pathology, Microbiology, and Immunology, University of California, Davis, School of Veterinary Medicine and Adjunct Professor of Medicine, University of California, Davis, School of Medicine 

Human Clinical Trials

  • Julie McElrath, Member of the Fred Hutchinson Cancer Research Center and Professor in the University of Washington Department of Medicine
  • Harriet Robinson, Chief Scientific Officer, GeoVax Inc. 

Ethical Guidelines and Clinical Trials

  • Jerome Kim, Deputy Director (Science) and Chief, Department of Molecular Virology and Pathogenesis, Division of Retrovirology Walter Reed Army Institute of Research (U.S. Military HIV Research Program) 

 

The meeting will conclude with a panel discussion on the topic, “Where Are We Going and What's Next?” A networking reception will follow.

AttachmentSize
Press Release17.57 KB
NYAS Vaccine Symposium Flyer207.61 KB